HNGE Hinge Health, Inc. Class A Common Stock
$54,85
Prezzo · Mag 20, 2026
Fondamentali al Mag 7, 2026
Intervallo 52 sett.
$30–$62
77% of range
Rating Analisti
BUY
22 analysts
Prezzo Obiettivo
$71
+29% upside
P/E (TTM)
-6.0
ROE
-299.8%
Margine di Profitto Netto
-89.9%
HNGE Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$54.85
Capitalizzazione di Mercato
$0
P/E (TTM)
-6.0
EPS (TTM)
$-7.77
Ricavi (TTM)
$588M
Rendimento div.
—
ROE
-299.8%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$30 – $62
HNGE Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$588M
2023-12-31
→
2025-12-31
EPS
$-7.77
2023-12-31
→
2025-12-31
Flusso di cassa libero
$171M
2025-12-31
→
2025-12-31
Margini
-89.9%
2025-12-31
→
2025-12-31
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
HNGE
Mediana dei peer
P/E (TTM)
-6.0
92.0
P/S (TTM)
0.0
2.1
Price / FCF (Prezzo / FCF)
0.0
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
HNGE
Mediana dei peer
Gross Margin (Margine lordo)
79.7%
20.2%
Operating Margin (Margine Operativo)
-92.9%
—
Net Profit Margin (Margine di Profitto Netto)
-89.9%
1.2%
ROA
-74.5%
1.1%
ROE
-299.8%
2.3%
ROIC
-306.4%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
HNGE
Mediana dei peer
Current Ratio (Rapporto corrente)
1.5
1.6
Quick Ratio
0.8
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
HNGE
Mediana dei peer
Revenue YoY (Ricavi YoY)
50.6%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
HNGE
Mediana dei peer
HNGE Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
22 analisti
- Acquisto forte 4 18,2%
- Compra 16 72,7%
- Mantieni 2 9,1%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
15 analisti · 2026-05-17
Mediana
$70.00
← Sotto tutti i target
$54.85
Basso
$55.00
Alto
$95.00
Target mediano
$70.00
+27,6%
Target medio
$70.73
+29,0%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.25%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 31 Marzo 2026 | $0.45 | $0.39 | 0.06% |
| 31 Dicembre 2025 | $0.49 | $0.40 | 0.09% |
| 30 Settembre 2025 | $0.44 | $0.23 | 0.21% |
| 30 Giugno 2025 | $0.71 | $0.09 | 0.62% |
Confronto tra pari Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| RDNT | $5.28B | -285.4 | 11.5% | -0.91% | -1.9% | — |
| BLLN | $0 | 584.6 | 100.0% | 2.4% | 6.5% | 68.3% |
| OPCH | $5.00B | 25.1 | 13.0% | 3.7% | 15.4% | 19.3% |
| CRVL | $5.75B | 61.2 | 12.6% | 10.6% | 30.6% | 23.4% |
| LFST | $2.73B | — | 13.9% | 0.68% | 0.65% | — |
| PRVA | $2.93B | 131.7 | 22.3% | 1.1% | 3.3% | — |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 16
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $588M | $390M | $293M | |
| Cost of Revenue | $120M | $91M | $99M | |
| Gross Profit | $468M | $300M | $194M | |
| R&D Expense | $368M | $101M | $110M | |
| SG&A Expense | $330M | $64M | $67M | |
| Operating Expenses | $1.01B | $332M | $325M | |
| Operating Income | $-546M | $-32M | $-131M | |
| Other Non-op | $19M | $21M | $22M | |
| Pretax Income | $-527M | $-11M | $-109M | |
| Income Tax | $998.0K | $677.0K | $-405.0K | |
| Net Income | $-528M | $-12M | $-108M | |
| EPS (Basic) | $-7.77 | $-0.88 | $-8.31 | |
| EPS (Diluted) | $-7.77 | $-0.88 | $-8.31 | |
| Shares (Basic) | 54,577,000 | 13,558,000 | 13,017,000 | |
| Shares (Diluted) | 54,577,000 | 13,558,000 | 13,017,000 | |
| EBITDA | $-546M | · | · |
Stato Patrimoniale 25
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $208M | $301M | $235M | |
| Short-term Investments | · | $166M | · | |
| Receivables | $66M | $42M | · | |
| Inventory | $16M | $11M | · | |
| Prepaid Expense | $57M | $45M | · | |
| Other Current Assets | $6M | $7M | · | |
| Current Assets | $534M | $583M | · | |
| PP&E (Net) | $10M | $7M | · | |
| PP&E (Gross) | $30M | $24M | · | |
| Accum. Depreciation | $20M | $17M | · | |
| Goodwill | $64M | $62M | · | |
| Intangibles | $3M | $2M | · | |
| Other Non-current Assets | $14M | $9M | · | |
| Total Assets | $745M | $673M | · | |
| Accounts Payable | $57M | $28M | · | |
| Current Liabilities | $362M | $249M | · | |
| Capital Leases | $4M | $7M | · | |
| Total Liabilities | $366M | $257M | · | |
| Common Stock | · | $0 | · | |
| Paid-in Capital | $1.23B | $88M | · | |
| Retained Earnings | $-1.05B | $-523M | · | |
| AOCI | $-20.0K | $68.0K | · | |
| Stockholders' Equity | $179M | $-435M | $-424M | |
| Liabilities + Equity | $745M | $673M | · | |
| Shares Outstanding | 79,171,304 | 16,379,906 | 15,956,516 |
Flusso di cassa 13
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $5M | $6M | $6M | |
| Stock-based Comp | $643M | $739.0K | $2M | |
| Deferred Tax | $53.0K | $-585.0K | $-473.0K | |
| Amort. of Intangibles | $900.0K | $400.0K | $400.0K | |
| Operating Cash Flow | $171M | $49M | $-64M | |
| CapEx | $708.0K | $1M | $2M | |
| Investing Cash Flow | $-114M | $18M | $2M | |
| Stock Issued | $8M | $0 | $0 | |
| Stock Repurchased | $65M | $0 | $0 | |
| Net Stock Activity | $-57M | · | · | |
| Financing Cash Flow | $-150M | $-2M | $-3M | |
| Taxes Paid | $2M | $0 | $0 | |
| Free Cash Flow | $171M | · | · |
Redditività 8
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross Margin | 79.7% | · | · | |
| Operating Margin | -92.9% | · | · | |
| Net Margin | -89.9% | · | · | |
| Pretax Margin | -89.7% | · | · | |
| EBITDA Margin | -92.9% | · | · | |
| ROA | -74.5% | · | · | |
| ROE | -299.8% | · | · | |
| ROIC | -306.4% | · | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 1.5 | · | · | |
| Quick Ratio | 0.8 | · | · |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.8 | · | · | |
| Inventory Turnover | 9.0 | · | · | |
| Receivables Turnover | 10.8 | · | · |
Tassi di Crescita 1
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 50.6% | 33.4% | · |
Valutazione (TTM) 9
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $588M | · | · | |
| Net Income TTM | $-528M | · | · | |
| Market Cap | $0 | · | · | |
| P/E | -6.0 | · | · | |
| P/S | 0.0 | · | · | |
| P / Tangible Book | 0.0 | · | · | |
| P / Cash Flow | 0.0 | · | · | |
| P / FCF | 0.0 | · | · | |
| Earnings Yield | -16.7% | · | · |
Conto Economico 16
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $182M | $171M | $154M | $139M | $124M | $117M | $101M | |
| Cost of Revenue | $28M | $27M | $28M | $41M | $24M | $21M | $21M | |
| Gross Profit | $154M | $144M | $126M | $98M | $100M | $96M | $79M | |
| R&D Expense | $30M | $33M | $32M | $280M | $23M | $22M | $24M | |
| SG&A Expense | $23M | $25M | $37M | $251M | $17M | $17M | $15M | |
| Operating Expenses | $122M | $117M | $132M | $678M | $87M | $75M | $83M | |
| Operating Income | $32M | $27M | $-6M | $-581M | $13M | $21M | $-4M | |
| Other Non-op | $4M | $5M | $4M | $5M | $5M | $5M | $5M | |
| Pretax Income | $36M | $32M | $-2M | $-576M | $18M | $26M | $1M | |
| Income Tax | $814.0K | $122.0K | $206.0K | $-326.0K | $998.0K | $-951.0K | $1M | |
| Net Income | $35M | $32M | $-2M | $-576M | $17M | $27M | $341.0K | |
| EPS (Basic) | $0.43 | $2.11 | $-0.02 | $-13.10 | $7.91 | $2.01 | $0.01 | |
| EPS (Diluted) | $0.41 | $2.11 | $-0.02 | $-13.10 | $1.31 | $2.01 | $0.01 | |
| Shares (Basic) | 78,619,000 | 8,404,000 | 78,858,000 | 43,931,000 | 15,332,000 | 46,000 | 13,623,000 | |
| Shares (Diluted) | 82,394,000 | 8,404,000 | 78,858,000 | 43,931,000 | 92,746,000 | 46,000 | 16,584,000 | |
| EBITDA | $32M | · | $-6M | $-581M | · | · | · |
Stato Patrimoniale 25
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $187M | $208M | $261M | $237M | · | $301M | · | |
| Short-term Investments | · | · | $219M | $176M | · | · | · | |
| Receivables | $115M | $66M | $87M | $99M | · | $42M | · | |
| Inventory | $14M | $16M | $14M | $14M | · | $11M | · | |
| Prepaid Expense | $61M | $57M | $49M | $48M | · | $45M | · | |
| Other Current Assets | $7M | $6M | · | · | · | $7M | · | |
| Current Assets | $540M | $534M | $659M | $598M | · | $583M | · | |
| PP&E (Net) | $11M | $10M | $8M | $8M | · | $7M | · | |
| PP&E (Gross) | $32M | $30M | $28M | $26M | · | $24M | · | |
| Accum. Depreciation | $20M | $20M | $20M | $19M | · | $17M | · | |
| Goodwill | $64M | $64M | $64M | $64M | · | $62M | · | |
| Intangibles | $2M | $3M | $3M | $3M | · | $2M | · | |
| Other Non-current Assets | $15M | $14M | $13M | $12M | · | $9M | · | |
| Total Assets | $729M | $745M | $770M | $694M | · | $673M | · | |
| Accounts Payable | $69M | $57M | $53M | $35M | · | $28M | · | |
| Current Liabilities | $414M | $362M | $357M | $314M | · | $249M | · | |
| Capital Leases | $3M | $4M | $5M | $6M | · | $7M | · | |
| Total Liabilities | $417M | $366M | $362M | $320M | · | $257M | · | |
| Common Stock | · | · | $0 | $0 | · | $0 | · | |
| Paid-in Capital | $1.13B | $1.23B | $1.29B | $1.26B | · | $88M | · | |
| Retained Earnings | $-1.02B | $-1.05B | $-1.08B | $-1.08B | · | $-523M | · | |
| AOCI | $-348.0K | $-20.0K | $53.0K | $-34.0K | · | $68.0K | · | |
| Stockholders' Equity | $112M | $179M | $208M | $174M | · | $-435M | · | |
| Liabilities + Equity | $729M | $745M | $770M | $694M | · | $673M | · | |
| Shares Outstanding | 77,304,138 | 0 | 0 | 0 | · | 16,379,906 | · |
Flusso di cassa 12
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Stock-based Comp | $12M | $17M | $35M | $591M | $7.0K | $14.0K | $115.0K | |
| Deferred Tax | $0 | $-93.0K | $50.0K | $90.0K | $6.0K | · | · | |
| Amort. of Intangibles | $200.0K | $300.0K | $200.0K | $200.0K | $200.0K | $100.0K | $100.0K | |
| Operating Cash Flow | $43M | $64M | $82M | $20M | $5M | $38M | $28M | |
| CapEx | $83.0K | $408.0K | $52.0K | $197.0K | $51.0K | $157.0K | $315.0K | |
| Investing Cash Flow | $48M | $-38M | $-59M | $4M | $-21M | $-3M | $3M | |
| Stock Repurchased | $105M | · | · | · | $0 | · | · | |
| Net Stock Activity | $-105M | · | · | · | · | · | · | |
| Financing Cash Flow | $-113M | $-80M | $531.0K | $-76M | $4M | $-2M | $-19.0K | |
| Taxes Paid | $501.0K | $346.0K | $1M | $199.0K | $0 | · | · | |
| Free Cash Flow | $43M | · | · | · | · | · | · |
Redditività 8
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 84.6% | · | 81.8% | 70.3% | · | · | · | |
| Operating Margin | 17.6% | · | -4.0% | -417.4% | · | · | · | |
| Net Margin | 19.3% | · | -1.2% | -413.8% | · | · | · | |
| Pretax Margin | 19.7% | · | -1.1% | -414.1% | · | · | · | |
| EBITDA Margin | 17.6% | · | -4.0% | -417.4% | · | · | · | |
| ROA | 9.6% | · | -0.48% | -166.0% | · | · | · | |
| ROE | 62.9% | · | -1.8% | -662.5% | · | · | · | |
| ROIC | 28.1% | · | -3.3% | -334.0% | · | · | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | · | 1.8 | 1.9 | · | · | · | |
| Quick Ratio | 0.7 | · | 1.6 | 1.6 | · | · | · |
Efficienza 3
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.4 | 0.4 | · | · | · | |
| Inventory Turnover | 4.0 | · | 4.1 | 5.9 | · | · | · | |
| Receivables Turnover | 3.2 | · | 3.6 | 2.8 | · | · | · |
Valutazione (TTM) 10
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $599M | · | · | · | · | · | · | |
| Net Income TTM | $-525M | · | $-560M | $-571M | · | · | · | |
| Market Cap | $2.98B | · | $0 | $0 | · | · | · | |
| P/E | -3.4 | · | · | · | · | · | · | |
| P/S | 5.0 | · | · | · | · | · | · | |
| P/B | 26.7 | · | · | · | · | · | · | |
| P / Tangible Book | 65.8 | · | 0.0 | 0.0 | · | · | · | |
| P / Cash Flow | 69.2 | · | · | · | · | · | · | |
| P / FCF | 69.3 | · | · | · | · | · | · | |
| Earnings Yield | -29.6% | · | · | · | · | · | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ricavi | $588M | $390M | $293M |
| Margine Lordo % | 79.7% | — | — |
| Margine Operativo % | -92.9% | — | — |
| Utile netto | $-528M | $-12M | $-108M |
| EPS Diluito | $-7.77 | $-0.88 | $-8.31 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Rapporto corrente | 1.5 | — | — |
| Quick Ratio | 0.8 | — | — |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flusso di cassa libero | $171M | — | — |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.